Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 323706, 7 pages
http://dx.doi.org/10.1155/2015/323706
Research Article

Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke

1EA 3072, Fédération de Médecine Translationnelle de Strasbourg, Institut de Physiologie, Université de Strasbourg, 67000 Strasbourg, France
2Unité Neuro-Vasculaire, Service de Neurologie, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France
3CNRS, ICube UMR-7357, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, 67000 Strasbourg, France
4Service de Physiologie et d’Explorations Fonctionnelles, Pôle de Pathologie Thoracique Hôpitaux Universitaires, NHC, CHRU de Strasbourg, 67000 Strasbourg Cedex, France
5UMR CNRS 7213, Laboratoire de Biophotonique et Pharmacologie, Faculté de Pharmacie, Université de Strasbourg, 67401 Illkirch, France
6Laboratoire de Toxicologie, Institut de Médecine Légale, Université de Strasbourg, 67000 Strasbourg, France

Received 11 July 2014; Revised 15 September 2014; Accepted 22 September 2014

Academic Editor: Markus Kipp

Copyright © 2015 Valérie Wolff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. D. Volkow, R. D. Baler, W. M. Compton, and S. R. B. Weiss, “Adverse health effects of marijuana use,” The New England Journal of Medicine, vol. 370, no. 23, pp. 2219–2227, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. Ben Amar, “Cannabinoids in medicine: a review of their therapeutic potential,” Journal of Ethnopharmacology, vol. 105, no. 1-2, pp. 1–25, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. C. J. Fowler, “Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents: non-psychoactive cannabinoids, “entourage” compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects,” Brain Research Reviews, vol. 41, no. 1, pp. 26–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. G. E. Caldicott, J. Holmes, K. C. Roberts-Thomson, and L. Mahar, “Keep off the grass: marijuana use and acute cardiovascular events,” European Journal of Emergency Medicine, vol. 12, no. 5, pp. 236–244, 2005. View at Google Scholar · View at Scopus
  5. B. R. Thanvi and S. D. Treadwell, “Cannabis and stroke: Is there a link?” Postgraduate Medical Journal, vol. 85, no. 1000, pp. 80–83, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. V. Wolff, J.-P. Armspach, V. Lauer et al., “Cannabis-related stroke: myth or reality?” Stroke, vol. 44, no. 2, pp. 558–563, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. G. Thomas, R. A. Kloner, and S. Rezkalla, “Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know,” The American Journal of Cardiology, vol. 113, no. 1, pp. 187–190, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. V. Wolff, V. Lauer, O. Rouyer et al., “Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients,” Stroke, vol. 42, no. 6, pp. 1778–1780, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. H. Chen, H. Yoshioka, G. S. Kim et al., “Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection,” Antioxidants & Redox Signaling, vol. 14, no. 8, pp. 1505–1517, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. I. Olmez and H. Ozyurt, “Reactive oxygen species and ischemic cerebrovascular disease,” Neurochemistry International, vol. 60, no. 2, pp. 208–212, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. N. R. Sims and H. Muyderman, “Mitochondria, oxidative metabolism and cell death in stroke,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1802, no. 1, pp. 80–91, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Kindo, S. Gerelli, J. Bouitbir et al., “Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress,” Frontiers in Physiology, vol. 3, article 332, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. Z. Mansour, A. L. Charles, M. Kindo et al., “Remote effects of lower limb ischemia-reperfusion: impaired lung, unchanged liver and stimulated kidney oxidative capacities,” BioMed Research International, vol. 2014, Article ID 392390, 7 pages, 2014. View at Publisher · View at Google Scholar · View at PubMed
  14. A.-L. Charles, A.-S. Guilbert, J. Bouitbir et al., “Effect of postconditioning on mitochondrial dysfunction in experimental aortic cross-clamping,” British Journal of Surgery, vol. 98, no. 4, pp. 511–516, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. A. Meyer, J. Zoll, A. L. Charles et al., “Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: Ccentral actor and therapeutic target,” Experimental Physiology, vol. 98, no. 6, pp. 1063–1078, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. D. Duteil, C. Chambon, F. Ali et al., “The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles,” Cell Metabolism, vol. 12, no. 5, pp. 496–508, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. Garnier, J. Zoll, D. Fortin et al., “Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II,” Circulation: Heart Failure, vol. 2, no. 4, pp. 342–350, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. B. Costa and M. Colleoni, “Changes in rat brain energetic metabolism after exposure to anandamide or delta9-tetrahydrocannabinol,” European Journal of Pharmacology, vol. 395, no. 1, pp. 1–7, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. I. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, “Evaluation of oxidative stress in patients with acute ischemic stroke,” Romanian Journal of Internal Medicine, vol. 51, no. 2, pp. 97–106, 2013. View at Google Scholar · View at Scopus
  20. S. Manzanero, T. Santro, and T. V. Arumugam, “Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury,” Neurochemistry International, vol. 62, no. 5, pp. 712–718, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Chrissobolis, A. A. Miller, G. R. Drummond, B. K. Kemp-Harper, and C. G. Sobey, “Oxidative stress and endothelial dysfunction in cerebrovascular disease,” Frontiers in Bioscience, vol. 16, no. 5, pp. 1733–1745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Popa-Wagner, S. Mitran, S. Sivanesan, E. Chang, and A.-M. Buga, “ROS and brain diseases: the good, the bad, and the ugly,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 963520, 14 pages, 2013. View at Publisher · View at Google Scholar · View at PubMed
  23. Y. Baratli, A.-L. Charles, V. Wolff et al., “Impact of iron oxide nanoparticles on brain, heart, lung, liver and kidneys mitochondrial respiratory chain complexes activities and coupling,” Toxicology in Vitro, vol. 27, no. 8, pp. 2142–2148, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. Y. Baratli, A.-L. Charles, V. Wolff et al., “Age Modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats,” BioMed Research International, vol. 2014, Article ID 474081, 10 pages, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. F. Thaveau, J. Zoll, O. Rouyer et al., “Ischemic preconditioning specifically restores complexes I and II activities of the mitochondrial respiratory chain in ischemic skeletal muscle,” Journal of Vascular Surgery, vol. 46, no. 3, pp. 541–547, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. E. J. Anderson and P. D. Neufer, “Type II skeletal myofibers possess unique properties that potentiate mitochondrial H2O2 generation,” The American Journal of Physiology—Cell Physiology, vol. 290, no. 3, pp. C844–C851, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Picard, D. Ritchie, M. M. Thomas, K. J. Wright, and R. T. Hepple, “Alterations in intrinsic mitochondrial function with aging are fiber type-specific and do not explain differential atrophy between muscles,” Aging Cell, vol. 10, no. 6, pp. 1047–1055, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. A. Whyte, S. Al-Hammadi, G. Balhaj, O. M. Brown, H. S. Penefsky, and A.-K. Souid, “Cannabinoids inhibit cellular respiration of human oral cancer cells,” Pharmacology, vol. 85, no. 6, pp. 328–335, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. Z. S. Badawy, K. R. Chohan, D. A. Whyte, H. S. Penefsky, O. M. Brown, and A.-K. Souid, “Cannabinoids inhibit the respiration of human sperm,” Fertility and Sterility, vol. 91, no. 6, pp. 2471–2476, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. Athanasiou, A. B. Clarke, A. E. Turner et al., “Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death,” Biochemical and Biophysical Research Communications, vol. 364, no. 1, pp. 131–137, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. Bartova and M. K. Birmingham, “Effect of Δ9 tetrahydrocannabinol on mitochondrial NADH oxidase activity,” Journal of Biological Chemistry, vol. 251, no. 16, pp. 5002–5006, 1976. View at Google Scholar · View at Scopus
  32. J. M. Mahoney and R. A. Harris, “Effect of delta9-tetrahydrocannabinol on mitochondrial processes,” Biochemical Pharmacology, vol. 21, no. 9, pp. 1217–1226, 1972. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Chiu, R. Karler, and C. Craven, “The influence of Δ9 tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption,” Research Communications in Chemical Pathology and Pharmacology, vol. 12, no. 2, pp. 267–286, 1975. View at Google Scholar · View at Scopus
  34. M. J. Freeman, D. Z. Rose, M. A. Myers, C. L. Gooch, A. C. Bozeman, and W. Scott Burgin, “Ischemic stroke after use of the synthetic marijuana ‘spice’,” Neurology, vol. 81, no. 24, pp. 2090–2093, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. E. J. Anderson, M. E. Lustig, K. E. Boyle et al., “Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans,” Journal of Clinical Investigation, vol. 119, no. 3, pp. 573–581, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. Ameri, “The effects of cannabinoids on the brain,” Progress in Neurobiology, vol. 58, no. 4, pp. 315–348, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Brunet, T. Hauet, W. Hébrard, Y. Papet, G. Mauco, and P. Mura, “Postmortem redistribution of THC in the pig,” International Journal of Legal Medicine, vol. 124, no. 6, pp. 543–549, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. Giroud, K. Michaud, F. Sporkert et al., “A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry (HILIC-MS),” Journal of Analytical Toxicology, vol. 28, no. 6, pp. 464–474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. L. Dembert and J. Harclerode, “Effects of 1-Δ9-tetrahydrocannabinol, dl-amphetamine and pentobarbital on oxygen consumption by mouse brain and heart homogenates,” Biochemical Pharmacology, vol. 23, no. 5, pp. 947–956, 1974. View at Google Scholar · View at Scopus
  40. B. L. Nazar, J. Harclerode, R. I. Roth, and R. C. Butler, “Acquisition of tolerance to Δ 9 THC as measured by the response of a cellular function,” Life Sciences, vol. 14, no. 12, pp. 2513–2520, 1974. View at Publisher · View at Google Scholar · View at Scopus
  41. T. A. Sarafian, N. Habib, M. Oldham et al., “Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 290, no. 6, pp. L1202–L1209, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. C. D. Verrico, J. D. Jentsch, R. H. Roth, and J. R. Taylor, “Repeated, intermittent Δ9-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention,” Neuropsychopharmacology, vol. 29, no. 3, pp. 522–529, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. L. V. Panlilio, C. Zanettini, C. Barnes, M. Solinas, and S. R. Goldberg, “Prior exposure to THC increases the addictive effects of nicotine in rats,” Neuropsychopharmacology, vol. 38, no. 7, pp. 1198–1208, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus